Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant human NADH (nicotinamide-adenine dinucleotide) dehydrogenase subunit-4 gene and constructing method of expression vector thereof

A technology for the construction of dehydrogenase subunit 4, which is applied in the field of recombinant human NADH dehydrogenase subunit 4 gene and its expression vector construction, which can solve the problems that human treatment cannot be used

Active Publication Date: 2012-08-15
WUHAN NEUROPHTH BIOTECHNOLOGY LTD CO
View PDF1 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Some people also use this technology in foreign research, but the nucleic acid sequences designed in foreign research are all added with green fluorescent protein (GFP), such nucleic acid sequences can be used in experimental research, but cannot be used in human treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant human NADH (nicotinamide-adenine dinucleotide) dehydrogenase subunit-4 gene and constructing method of expression vector thereof
  • Recombinant human NADH (nicotinamide-adenine dinucleotide) dehydrogenase subunit-4 gene and constructing method of expression vector thereof
  • Recombinant human NADH (nicotinamide-adenine dinucleotide) dehydrogenase subunit-4 gene and constructing method of expression vector thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] 1. Test materials

[0052] Table 1

[0053]

[0054] Two experimental steps

[0055]The new gene sequence of the recombinant human NADH dehydrogenase subunit 4 (ND4) of the present invention is redesigned according to the ND4 gene sequence and the cox10 gene sequence provided by the genbank database. The gene sequence of the present invention is designed in two parts ( figure 1 ). The first part includes the mitochondrial targeting sequence (mitochondroitin-targeting sequence MTS) of cox10 and the coding sequence of ND4. Among them, since the genetic codes of mtDNA and nuclear genome are not completely the same, the present invention modifies its gene sequence according to the amino acid sequence of ND4 protein, so that the amino acid sequence of the modified new gene sequence translated in the cytosol is the same as the ND4 protein sequence provided by the genbank database. The amino acid sequence translated in the mitochondria of the gene sequence is exactly t...

Embodiment 2

[0096] Example 2: Effect experiment of rAAV2 / 2-ND4 recombinant adeno-associated virus on Leber hereditary optic neuropathy

[0097] 1. Intravitreal Injection of Rabbit Eyes

[0098] Take 24 rabbits and divide them into two groups, divide them into experimental group and control group, respectively use 0.1% rAAV-ND4 and 0.1% rAAV-GFP to puncture the pars plana of the ciliary body 3mm away from the corneal limbus into the vitreous cavity, and perform vitrectomy. Body cavity injection.

[0099] 2. Slit lamp, intraocular pressure, fundus photography examination

[0100] The rabbits in the two groups were examined with slit lamp and intraocular pressure at 1, 3, 7, and 30 days after operation respectively. All rabbits had no obvious abnormalities, no conjunctival hyperemia, discharge, endophthalmitis, and no increase in intraocular pressure. Fundus photography one month after operation showed that all rabbits had no obvious complications or damage to retinal blood vessels and op...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a recombinant human NADH (nicotinamide-adenine dinucleotid) dehydrogenase subunit-4 gene and a constructing method of an expression vector thereof. The nucleotide sequence of the gene is shown in SEQ ID NO:1, and the size of the nucleotide sequence is 2889 bp. The constructing steps of adeno-associate virus vectors are as follows: firstly constructing a recombinant adeno-associated virus vector containing the human NADH dehydrogenase subunit-4 gene, and then coating, infecting, purifying, concentrating and identifying the recombinant adeno-associated virus. According to the method, the recombinant adeno-associated virus vector with the recombinant human NADH dehydrogenase subunit-4 gene can be quickly and simply constructed, and is packaged to obtain the adeno-associated virus vector with complex defects. The gene can be used for gene therapy of LHON (leber's hereditary optic neuropathy).

Description

technical field [0001] The invention relates to a recombinant human NADH dehydrogenase subunit 4 gene and a method for constructing an expression vector thereof, belonging to the technical field of genetic engineering. technical background [0002] Leber's hereditary optic neuropathy (LHON) is a mitochondrial hereditary disease that mainly affects the fibers of the macular papillary tract, leading to degeneration of the optic nerve. The disease usually occurs in young and middle-aged men, and the clinical manifestations are acute or subacute painless vision loss in both eyes at the same time or successively, accompanied by central visual field defect and color vision disturbance. [0003] LHON is caused by mutations in mitochondrial sites. Chinese scholars have preliminarily confirmed that more than 95% of LHON patients in China are related to site mutations in mitochondrial DNA 11778, 14484, and 3460, among which site 111778 is the most common mutation, accounting for 89.2%...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/53C12N15/66C12N15/864C12N7/01C12N1/15C12N1/19C12N1/21
Inventor 李斌裴晗万幸
Owner WUHAN NEUROPHTH BIOTECHNOLOGY LTD CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com